Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells
2007

Effects of HIF-1 Inhibition on Cancer Cell Sensitivity to Radiation

Sample size: 3 publication 10 minutes Evidence: moderate

Author Information

Author(s): Adrian Staab, Jürgen Loeffler, Harun M Said, Désirée Diehlmann, Astrid Katzer, Melanie Beyer, Markus Fleischer, Franz Schwab, Kurt Baier, Hermann Einsele, Michael Flentje, Dirk Vordermark

Primary Institution: University of Würzburg

Hypothesis

Does targeting HIF-1 with chetomin influence the radiosensitivity of hypoxic HT 1080 human fibrosarcoma cells?

Conclusion

HIF-1 inhibition by chetomin effectively reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro.

Supporting Evidence

  • Chetomin treatment significantly reduced CA9 and VEGF mRNA expression in hypoxic cells.
  • Chetomin reduced the modified oxygen enhancement ratio (OER') compared to untreated cells.
  • The study demonstrated that HIF-1 inhibition enhances radiation response under severely hypoxic conditions.

Takeaway

This study found that a drug called chetomin can help make cancer cells more sensitive to radiation by blocking a protein that helps them survive in low-oxygen conditions.

Methodology

HT 1080 cells were treated with chetomin and then exposed to hypoxia and radiation, followed by assays to measure gene expression and cell survival.

Limitations

The findings are limited to one in-vitro model and one HIF-1 targeting agent.

Participant Demographics

HT 1080 human fibrosarcoma cells were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-7-213

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication